Osaic Holdings
SNOA icon

Osaic Holdings’s Sonoma Pharmaceuticals SNOA Stock Holding History

Osaic Holdings’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06K Hold
500
– – ﹤0.01% 7247
2025
Q4 		$1.82K Buy
+500
New +$1.84K ﹤0.01% 7126
2024
Q4 		– Sell
-27
Closed -$82 – 7608
2024
Q3 		$82 Buy
27
+17
+170% +$87 ﹤0.01% 7257
2024
Q2 		$42 Buy
+10
New +$36 ﹤0.01% 7309
2023
Q4 		– Sell
-3
Closed -$38 – 7443
2023
Q3 		$38 Sell
3
-8
-73% -$156 ﹤0.01% 7290
2023
Q2 		$231 Hold
11
– – ﹤0.01% 7181
2023
Q1 		$210 Buy
11
+3
+38% +$77 ﹤0.01% 7261
2022
Q4 		$0 Hold
8
– – ﹤0.01% 7410
2022
Q3 		$0 Hold
8
– – ﹤0.01% 7491
2022
Q2 		$0 Hold
8
– – ﹤0.01% 7573
2022
Q1 		$1K Hold
8
– – ﹤0.01% 7114
2021
Q4 		$1K Hold
8
– – ﹤0.01% 7242
2021
Q3 		$1K Hold
8
– – ﹤0.01% 7072
2021
Q2 		$1K Sell
8
-7
-47% -$1.1K ﹤0.01% 6883
2021
Q1 		$2K Buy
15
+7
+88% +$1.13K ﹤0.01% 6523
2020
Q4 		$1K Hold
8
– – ﹤0.01% 6265
2020
Q3 		$1K Hold
8
– – ﹤0.01% 6069
2020
Q2 		$1K Hold
8
– – ﹤0.01% 5982
2020
Q1 		$1K Buy
+8
New +$806 ﹤0.01% 5911

Other funds holding SNOA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
MCWS
McKinley Carter Wealth Services Wheeling, West Virginia $1.73B AUM 17.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Osaic Holdings's SNOA Position: Q1 2026 in Review

Osaic Holdings held its Sonoma Pharmaceuticals (SNOA) position steady in Q1 2026 at 500 shares worth $1.06K. The position accounts for ﹤0.01% of the portfolio, ranked #7247.

Osaic Holdings first reported a position in SNOA in Q1 2020 and has held it in 19 quarters since. The position peaked at $2K in Q1 2021. 17 funds tracked by Wall St. Rank hold SNOA as of Q1 2026.

  • Osaic Holdings held 500 shares of Sonoma Pharmaceuticals worth $1.06K as of Q1 2026.
  • Osaic Holdings left its Sonoma Pharmaceuticals share count unchanged in Q1 2026.
  • Sonoma Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7247 holding.
  • Osaic Holdings first reported a position in Sonoma Pharmaceuticals in Q1 2020 and has held it in 19 quarters since.
  • Osaic Holdings's Sonoma Pharmaceuticals position peaked at $2K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.